Business
SANUWAVE Signs Distribution Partnership With Ametus Group, Setting Stage for Rapid Expansion in 2020
Re-Affirms Guidance of 110 dermaPACE® Placements in 2019 SUWANEE, GA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB:
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"Re-Affirms Guidance of 110 dermaPACE® Placements in 2019\n SUWANEE, GA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that it has signed a distribution partnership agreement with Ametus Group for the commercialization of the dermaPACE® System for the treatment of diabetic foot ulcers in the United States. Leveraging Ametus Group’s fifty dedicated wound care sales force allows SANUWAVE to ramp up placements much faster than previously expected in a cost effective and capital efficient manner. “Ametus Group leadership, along with our experienced and clinically consultative sales organization, are excited to partner with SANWUAVE to launch and drive market adoption of the cutting edge and unique PACE® technology utilized in dermaPACE®. We are very motivated by the positive clinical impact dermaPACE will have on thousands of diabetic patients with chronic foot ulcers,” stated Ametus Group co-founders and Managing Partners Randy Seeliger and Mark Will. “Our partnership with SANUWAVE and the dermaPACE® System are highly accretive with other innovative advanced wound care product offerings Ametus Group currently sells,” added Randy Seeliger and Mark Will. “The relationship with Ametus Group will allow SANUWAVE to enter markets more efficiently and on a cost-effective basis in 2020 and beyond. We chose Ametus Group based on their vast wound care experience backgrounds, and most importantly previous success,” stated Kevin Richardson, CEO and Chairman of SANUWAVE. “Ametus Group brings 50 wound care sales representatives to help train and sell dermaPACE Systems. The initial roll out is currently underway and covers Minnesota, Wisconsin, and Illinois. These are territories where NGS operates as a MAC, managing Medicare accounts. As we roll through in 2020, we will add mostly western states to the Ametus mix,” concluded Mr. Richardson. About SANUWAVE Health, Inc. SANUWAVE Health, Inc. (OTCQB:SNWV) (www.SANUWAVE.com) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic...